TREXIMET® (sumatriptan naproxen sodium) TREXIMET (sumatriptan naproxen sodium) is a prescription treatment approved by the FDA for acute treatment of migraine attacks, with or without aura, in adults Learn how TREXIMET may help your patients
Approval [Rx ONLY] - TREXIMET TREXIMET is a combination of sumatriptan, a serotonin (5-HT) 1b 1d receptor agonist (triptan), and naproxen sodium, a non-steroidal anti-inflammatory drug, indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older
MEDICATION GUIDE TREXIMET • serotonin syndrome Serotonin syndrome is a rare but serious problem that can happen in people using TREXIMET, especially if TREXIMET is used with antidepressant medicines called SSRIs or SNRIs